AXL and cancer: Although RTK signaling in general has been found to be enriched in HNC tumors from patients non-responsive to chemotherapy and radiation therapy [18], Axl signaling in particular is implicated in promoting cancer cell proliferation, survival, metastasis, and resistance to chemotherapy [15,16,17,19].